Algeta actively promotes a culture designed to build confidence and trust among its stakeholders.
Key elements of this culture include open and honest communication, a well-developed system of controls and polices and a compliance program. Algeta complies with applicable laws and applicable accounting standards and ensures that the information we supply to our auditors and stakeholders, such as investors, as well as regulatory agencies and government bodies provides a true and fair view of the financial situation and the Company.
Algeta has paid no dividend to date. The Company is focused on the development of novel pharmaceutical products and does not anticipate paying any cash dividend in the foreseeable future.
Investor Relations Policy
Algeta’s will provide the financial markets equally with sufficient information, enabling a fair market valuation of the share. We will maintain an open dialog with the financial community by presentations, analyst and investor meetings, and by providing information about the Company in stock exchanges notices, press releases and financial reports. Financial reports are published on a quarterly basis. Relevant information about the Company is available on Algeta’s website.
The Company’s main objective is to maximise the value of the investments made by its existing shareholders. Notices of general meetings will be sent to the shareholders no later than two weeks prior to the meeting and any supporting material will be sufficiently detailed and comprehensive